A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Ragweed Allergoid With MPL With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Patients Sensitized to Ragweed Pollen.
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2009
At a glance
- Drugs Monophosphoryl lipid A; Ragweed allergy immunotherapy
- Indications Hypersensitivity; Rhinoconjunctivitis
- Focus Adverse reactions; Pharmacodynamics
- 27 Oct 2009 New trial record